PMDA drug package insert
ピコスルファートナトリウム内用液0.75%「イワキ」
PMDA Prescription drug · 岩城製薬株式会社 · package insert Jul 20, 2023
Key facts
| Brand names | ピコスルファートナトリウム内用液0.75%「イワキ」 |
|---|---|
| Nonproprietary names | ピコスルファートナトリウム水和物 |
| Companies | 製造販売元／岩城製薬株式会社 |
| Product type | Prescription drug |
| Therapeutic category | 液剤型緩下剤・大腸検査前処置用下剤 |
| Therapeutic category codes | 872359 |
| YJ codes | 2359005S1348 |
| Approval numbers | 23100AMX00052 |
| Package insert edition | 第1版 |
| Package insert date | Jul 20, 2023 |
| PMDA document key | 130202_2359005S1348_1 |
| PMDA company code | 130202 |
At a glance
- 1–9 Package insert revisions
- 1–9 Related PMDA documents
- None Safety communications
- No PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: